1![CE Objectives and Evaluation Form appear on pageAn Overview of Lung Cancer Symptoms, Pathophysiology, And Treatment Linda H. Yoder CE Objectives and Evaluation Form appear on pageAn Overview of Lung Cancer Symptoms, Pathophysiology, And Treatment Linda H. Yoder](https://www.pdfsearch.io/img/3dca6a10bbab46d28dd4d4c4e2c09a88.jpg) | Add to Reading ListSource URL: c-changetogether.orgLanguage: English - Date: 2010-11-15 14:09:03
|
---|
2![ZAI Lab announces a global licensing agreement with Sanofi for a novel compound to potentially treat NSCLC ShanghaiZAI Lab Limited (ZAI Lab), an innovative biotech company based in China, announced today ZAI Lab announces a global licensing agreement with Sanofi for a novel compound to potentially treat NSCLC ShanghaiZAI Lab Limited (ZAI Lab), an innovative biotech company based in China, announced today](https://www.pdfsearch.io/img/076870fab465fc8f11ddf6c0e8bea36f.jpg) | Add to Reading ListSource URL: www.zailaboratory.comLanguage: English - Date: 2015-07-30 22:49:46
|
---|
3![DOI:http://dx.doi.orgAPJCPFrequency of EGFR Mutations in Non-small Cell Lung Cancer Patients: Screening Data from West Siberia RESEARCH ARTICLE Frequency of EGFR Mutations in Non-small Cell Lung C DOI:http://dx.doi.orgAPJCPFrequency of EGFR Mutations in Non-small Cell Lung Cancer Patients: Screening Data from West Siberia RESEARCH ARTICLE Frequency of EGFR Mutations in Non-small Cell Lung C](https://www.pdfsearch.io/img/97fef493c8e5b82b1305b30daa3b28e1.jpg) | Add to Reading ListSource URL: www.apocpcontrol.orgLanguage: English - Date: 2015-02-24 21:55:42
|
---|
4![Axelar announces final data from Phase II study with AXL1717 in lung cancer STOCKHOLM, SWEDEN – December 27, 2013. Axelar AB announced today the final results from its Phase II study AXL-003 in patients with non-small Axelar announces final data from Phase II study with AXL1717 in lung cancer STOCKHOLM, SWEDEN – December 27, 2013. Axelar AB announced today the final results from its Phase II study AXL-003 in patients with non-small](https://www.pdfsearch.io/img/a4d963205a162a6ebec1ba1cdf186450.jpg) | Add to Reading ListSource URL: axelar.seLanguage: English - Date: 2014-01-10 05:03:26
|
---|
5![Thoracic Oncology Introduction Research Activities The Division of Thoracic Oncology cares for Thoracic Oncology Introduction Research Activities The Division of Thoracic Oncology cares for](https://www.pdfsearch.io/img/eef4389e4841d32a5883ec2476276d1f.jpg) | Add to Reading ListSource URL: www.ncc.go.jpLanguage: English - Date: 2014-03-30 02:19:55
|
---|
6![Journal of Translational Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Pei regimen: a therapeutic Journal of Translational Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Pei regimen: a therapeutic](https://www.pdfsearch.io/img/67fb089090f94f8ac1b91c8545d3557e.jpg) | Add to Reading ListSource URL: www.translational-medicine.comLanguage: English |
---|
7![Lung cancer search filters: Connecting to the evidence Damarell R1, Tieman J1, Olver I2, Currow D1 There can be many challenges in finding needed literature and evidence in health activities. This study aimed to develop Lung cancer search filters: Connecting to the evidence Damarell R1, Tieman J1, Olver I2, Currow D1 There can be many challenges in finding needed literature and evidence in health activities. This study aimed to develop](https://www.pdfsearch.io/img/9169e722e4fcfe02c687c24a6b071a3d.jpg) | Add to Reading ListSource URL: www.caresearch.com.auLanguage: English - Date: 2011-11-09 19:00:26
|
---|
8![LUNG CANCER HUB SYNERGY POINT LUNG CANCER HUB SYNERGY POINT](https://www.pdfsearch.io/img/da3102122d358a6bcc9ca60a3430696b.jpg) | Add to Reading ListSource URL: www.singaporecancersociety.org.sgLanguage: English - Date: 2013-04-28 22:15:48
|
---|
9![Journal of IMAB - Annual Proceeding (Scientific Papers) vol. 16, book 3, 2010 OUR EXPERIENCE WITH TOPOTECAN AS SECOND- LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER Deyan Davidov, Journal of IMAB - Annual Proceeding (Scientific Papers) vol. 16, book 3, 2010 OUR EXPERIENCE WITH TOPOTECAN AS SECOND- LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER Deyan Davidov,](https://www.pdfsearch.io/img/485bd36f0a3b40578b6fec8de9de8db8.jpg) | Add to Reading ListSource URL: www.journal-imab-bg.orgLanguage: English - Date: 2011-03-18 03:48:32
|
---|
10![DOI: jimabJournal of IMAB - Annual Proceeding (Scientific Papers) 2008, vol. 14, book 1 GEMCITABINE / PLATINUM VS. VINORELBINEPLATINUM IN PATIENTS WITH ADVANCED NONSMALL- CELL LUNG CANCER Deyan Davi DOI: jimabJournal of IMAB - Annual Proceeding (Scientific Papers) 2008, vol. 14, book 1 GEMCITABINE / PLATINUM VS. VINORELBINEPLATINUM IN PATIENTS WITH ADVANCED NONSMALL- CELL LUNG CANCER Deyan Davi](https://www.pdfsearch.io/img/a5b271c3e443f940147a3c6f780b3c03.jpg) | Add to Reading ListSource URL: www.journal-imab-bg.orgLanguage: English - Date: 2011-11-02 17:53:49
|
---|